Smart new antiviral concept--DRACO at MIT Lincoln Lab--Todd Rider http://web.mit.edu/newsoffice/2011/antiviral-0810.html Have to see if the concept can actually work in vivo. There could be some catch. One catch could arise if there are "good" viruses we actually need to be active, or some pervasive harmless type. Because the treatment concept seems to go after all active viruses indiscriminately. It causes the host cell to self-destruct wherever double-stranded RNA is being produced (dsRNA is produced during viral replication). Looks good in vitro and preliminary trials in mice but has not been tried in larger animals. Here's a link to some PR about Todd Rider and Lincoln Lab. http://www.ll.mit.edu/60thAnniversary/rider.html "Rider had the idea to combine a dsRNA-binding protein with another protein that induces cells to undergo apoptosis (programmed cell suicide) — launched, for example, when a cell determines it is en route to becoming cancerous. Therefore, when one end of the DRACO binds to dsRNA, it signals the other end of the DRACO to initiate cell suicide..."